Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00120107 · ClinicalTrials.gov registry record · NA
Tea's Effect on Atherosclerosis Pilot Study (TEA Study)
A NA study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT00120107 is a NA study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 30 participants.
The verdict
NCT00120107, a NA study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The researchers propose a pilot study of the effect of long-term tea intake on atherosclerosis. Thirty patients at high risk for cardiovascular disease will be recruited and randomized to a six-month period of consumption of 3 cups per day of either tea, supplied as black tea solids readily dissolved in hot or cold liquid, or water. At baseline and after 6 months, atherosclerosis in the aorta will be assessed using magnetic resonance imaging. The primary outcomes of this pilot study will be compliance with tea intake and 2 MRI examinations. As secondary outcomes, standard and novel cardiovascular risk markers, including inflammatory, prothrombotic, fibrinolytic, vascular and metabolic factors will be measured. If successful, this pilot study will form the basis for a larger, long-term randomized trial to determine the effect of tea consumption on progression of atherosclerosis.
Interventions
- DRUG Black Tea
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2003-07 |
| Est. Completion | 2005-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00120107
The ClinicalTrials.gov registry entry for NCT00120107 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Black Tea is the first listed.
NCT00120107 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00120107 about?
NCT00120107 is a clinical study titled "Tea's Effect on Atherosclerosis Pilot Study (TEA Study)". The researchers propose a pilot study of the effect of long-term tea intake on atherosclerosis. Thirty patients at high risk for cardiovascular disease will be recruited and randomized to a six-month period of consumption of 3 cups per day of either tea, supplied as black tea solids readily dissolve...
What is the current status of trial NCT00120107?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2003-07. Estimated completion is 2005-04.
What interventions are being tested in trial NCT00120107?
The interventions under investigation include: Black Tea (DRUG).
Who is sponsoring clinical trial NCT00120107?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.